Trial Profile
Pharmacodynamics of prasugrel versus clopidogrel in Japanese patients with stable coronary artery disease (CAD) undergoing elective PCI
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jul 2012
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Aspirin; Clopidogrel
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics
- 01 Aug 2011 New trial record
- 28 Jul 2011 Results presented at the 23rd Congress of the International Society on Thrombosis and Haemostasis.